CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin
Cancer Research and Treatment. 2015;47(4):781-789.   Published online 2015 February 16    DOI: https://doi.org/10.4143/crt.2014.261

Excel Download

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
Cancer Research and Treatment. 2015;47(4):781-789   Crossref logo
Link1 Link2 Link3

A Multicenter, Randomized, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of Combination Docetaxel and Carboplatin and Sequential Therapy With Docetaxel Then Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Yearbook of Oncology. 2012;2012:103-104   Crossref logo
Link1 Link2

O-4 A randomized phase II study of docetaxel versus docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first line chemotherapy
Lung Cancer. 2003;41:S5   Crossref logo
Link1 Link2

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy
Yearbook of Oncology. 2008;2008:219-221   Crossref logo
Link1 Link2

A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-?2a in patients with advanced malignant melanoma
Cancer Immunology Immunotherapy. 1994;38(6):379-384   Crossref logo
Link1 Link2 Link3 Link4

5054 Safety and efficacy of the combination of trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: phase II results
European Journal of Cancer Supplements. 2009;7(2):276   Crossref logo
Link1 Link2

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens
Yearbook of Medicine. 2011;2011:120-121   Crossref logo
Link1 Link2

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens
Yearbook of Oncology. 2011;2011:32-33   Crossref logo
Link1 Link2

P92 Docetaxel versus epirubicin/cyclophosphamide (EC)as first-line therapy in metastatic breast cancer (MBC): results from the randomized phase II TIPP study
The Breast. 2005;14:S41   Crossref logo
Link1 Link2

Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC). Final results of a Phase II study
European Journal of Cancer. 2002;38(11):S68   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.